- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Stage IIIB Ovarian Epithelial Cancer in Switzerland
Total 184 results
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedChildhood Teratoma | Stage II Malignant Testicular Germ Cell Tumor | Stage III Malignant Testicular Germ Cell Tumor | Childhood Embryonal Tumor | Childhood Extracranial Germ Cell Tumor | Childhood Extragonadal Germ Cell Tumor | Childhood Malignant Ovarian Germ Cell Tumor | Childhood Malignant Testicular... and other conditionsUnited States, Canada, Australia, New Zealand, Puerto Rico, Switzerland
-
Oncology Institute of Southern SwitzerlandInstitute of Oncology ResearchRecruitingEpithelial Ovarian CancerSwitzerland
-
Cantonal Hospital of St. GallenTerminatedEpithelial Ovarian Cancer | Fallopian Tube CarcinomaSwitzerland
-
Swiss Group for Clinical Cancer ResearchCompletedOvarian CancerSwitzerland
-
Novartis PharmaceuticalsTerminatedRenal Cell Carcinoma | Epithelial Ovarian CancerJapan, Australia, Belgium, Spain, United States, Switzerland
-
ETOP IBCSG Partners FoundationNational Cancer Institute (NCI); NCIC Clinical Trials Group; Cancer and Leukemia... and other collaboratorsActive, not recruitingRecurrent Breast Carcinoma | Stage IIIA Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Estrogen Receptor Positive Breast Cancer | Progesterone Receptor Positive TumorUnited States, Canada, Switzerland
-
EBMT Solid Tumors Working PartyCompletedOvarian CancerSwitzerland, Spain, United Kingdom, Italy, Slovakia, Germany, Belgium, Austria, Czech Republic
-
Stiftung Swiss Tumor InstituteKlinik Hirslanden, Zurich; Manja Gideon FoundationTerminatedOvarian Neoplasms | Patient Reported Outcome MeasuresSwitzerland
-
Millennium Pharmaceuticals, Inc.WithdrawnOvarian CancerItaly, Switzerland
-
Ludwig Institute for Cancer ResearchCelgene; Cancer Research Institute, New York City; MedImmune LLCCompletedOvarian CancerUnited States, Switzerland
-
University of Lausanne HospitalsUniversity Hospital, Zürich; Cantonal Hospital of St. GallenCompletedMetastatic Ovarian Cancer | Metastatic Cancer LungSwitzerland
-
Goethe UniversityActive, not recruitingAnal Cancer | Anal Carcinoma | Anal Cancer Stage III | Anal Cancer Stage IIGermany, Switzerland, Austria
-
SanofiRegeneron PharmaceuticalsCompletedNeoplasms | Cancer of the OvaryUnited States, France, Canada, Australia, Germany, Italy, Netherlands, Portugal, Spain, Sweden, Switzerland
-
AbbVie (prior sponsor, Abbott)BiogenCompletedOvarian Cancer, Primary Peritoneal CancerUnited States, Australia, Belgium, Italy, Poland, Russian Federation, Spain, Sweden, Switzerland
-
University Hospital, GenevaSuspendedStage IB Skin Melanoma | Stages III Skin Melanoma | Stages II Skin MelanomaSwitzerland
-
TheraOpAstraZenecaActive, not recruitingStage III Non-small Cell Lung Cancer | Locally Advanced | UnresectableSwitzerland
-
AmgenNo longer availableUnresected Stage IIIB to IVM1c MelanomaSwitzerland
-
AmgenActive, not recruitingNon-squamous Non-small Cell Lung Cancer | Epithelial Ovarian Cancer | Claudin 6-positive Advanced/Metastatic Malignant Solid TumorsUnited States, Australia, Switzerland
-
NovoCure Ltd.UnknownOvarian CarcinomaSwitzerland, Belgium, Germany, Spain
-
European Organisation for Research and Treatment...CompletedOvarian CancerFrance, Spain, United Kingdom, Belgium, Israel, Switzerland, Italy
-
ImmunoGen, Inc.Gynecologic Oncology GroupCompletedOvarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CarcinomaUnited States, France, Canada, Spain, Switzerland, Belgium, Italy, United Kingdom, Ireland, Russian Federation, Bosnia and Herzegovina, Czechia, Serbia
-
AstraZenecaParexel; Covance; Iqvia Pty Ltd; Theradex; Myriad Genetics, Inc.CompletedNon-Germline BRCA Mutated Ovarian CancerItaly, Spain, Sweden, Canada, Czechia, Poland, United Kingdom, Israel, Austria, Belgium, Switzerland, Netherlands, Bulgaria, Finland, Norway, Denmark, Slovenia, Portugal
-
Dr Jean Yannis PERENTESRecruitingCarcinoma, Non-Small-Cell Lung | Gastric Cancer | Esophageal Cancer | Ovarian Cancer | Mesothelioma, Malignant | Carcinoma Breast Stage IVSwitzerland
-
University of BaselRecruitingLynch Syndrome | Hereditary Breast and Ovarian CancerSwitzerland
-
National Cancer Institute, NaplesMario Negri Institute for Pharmacological ResearchActive, not recruitingRecurrent Ovarian CancerFrance, Italy, Switzerland, Monaco, Greece
-
Swiss Group for Clinical Cancer ResearchActive, not recruiting
-
AmgenCompletedCompletely Resectable Stage IIIB, IIIC, or IVM1a MelanomaUnited States, Poland, France, Russian Federation, Spain, Australia, Greece, Switzerland, Brazil
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyActive, not recruitingAdvanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification | Lung Adenocarcinoma Stage IIIB/IVSpain, Taiwan, United States, Korea, Republic of, Netherlands, Israel, Belgium, Italy, China, France, Germany, Japan, Poland, Austria, Switzerland
-
Swiss Group for Clinical Cancer ResearchCompleted
-
Kantonsspital Winterthur KSWCompletedRenal Cell Carcinoma | Breast Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Urothelial Carcinoma | Pleural Mesothelioma | Gastro-Intestinal CancerSwitzerland
-
Manuela EicherSwiss Cancer League; Lindenhofgruppe AGCompletedBreast Neoplasm | Self-Management | Intervention | Cancer Survivorship | Early-Stage Breast CancerSwitzerland
-
University of ZurichCompletedMelanoma Stage III or IV | No Prior ChemotherapySwitzerland
-
Astellas Pharma IncCompletedOvarian Cancer | Solid TumorsUnited States, United Kingdom, Australia, Canada, Switzerland, Czechia, Italy, Poland, Romania, Russian Federation
-
Mario Negri Institute for Pharmacological ResearchPharmaMar; Averion International CorporationCompletedOvarian CancerAustria, Belgium, Norway, Spain, Finland, United Kingdom, Italy, Denmark, Germany, Netherlands, Switzerland
-
AmgenTerminatedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerUnited States, Belgium, Germany, Italy, United Kingdom, Canada, Denmark, Switzerland, Hong Kong, Austria, Slovakia, Taiwan, Hungary, France, Singapore, Australia, Poland, New Zealand
-
AGO Research GmbHHoffmann-La RocheActive, not recruitingRecurrent Ovarian CarcinomaNorway, Spain, France, Switzerland, Denmark, Germany, Sweden, Belgium, Finland, Austria, Estonia, Lithuania
-
Cristiana SessaCompletedBreast Cancer | NSCLC | Endometrial Cancer | Ovary Cancer | Small Cell Lung Cancer (SCLC) | Head and Neck (HNSCC)Switzerland
-
Hoffmann-La RocheCompletedOvarian CancerFrance, Spain, Sweden, Hong Kong, Canada, Switzerland, Estonia, Greece, Russian Federation, Hungary, Austria, Bulgaria, Netherlands, Latvia, Italy, Slovenia, Turkey, Serbia, Israel, Argentina, Brazil, Slovakia, Lithuania, Poland, Portugal, Mexi... and more
-
PfizerTerminatedOvarian CancerUnited States, Canada, United Kingdom, Korea, Republic of, Netherlands, Hong Kong, Singapore, Ireland, Estonia, Japan, Taiwan, Italy, Turkey, Slovakia, Germany, Poland, Switzerland, Croatia, Hungary, Bulgaria, Latvia, Mexico, Romania, Russian Federation and more
-
Swiss Group for Clinical Cancer ResearchCompleted
-
AstraZenecaRTI Health Solutions; A+A Healthcare Marketing Research; Freelance CRA (FCRA)CompletedPlatinum-sensitive Recurrent Serous Ovarian CancerFrance, Italy, Korea, Republic of, Spain, United Kingdom, Germany, Belgium, Israel, Portugal, Netherlands, Switzerland, Canada, Australia
-
University of BaselNational Cancer Center, Korea; University Hospital, Geneva; Swiss National Science... and other collaboratorsRecruitingBreast Cancer | Ovarian Cancer | Hereditary CancerSwitzerland
-
Martin-Luther-Universität Halle-WittenbergRadiation Oncology Working Group of the German Cancer SocietyCompletedNon Small Cell Lung Cancer Stage IIIGermany, Austria, Belgium, Spain, Switzerland
-
European Organisation for Research and Treatment...UnknownNon-small Cell Lung Cancer Stage I | Non-small Cell Lung Cancer Stage IIGermany, Belgium, United Kingdom, Switzerland
-
MorphotekEisai Europe Ltd. (United Kingdom)TerminatedOvarian CancerUnited States, Hong Kong, Netherlands, Spain, Korea, Republic of, Belgium, Taiwan, Israel, Japan, France, United Kingdom, Singapore, Italy, Argentina, India, Germany, Hungary, Australia, Portugal, Russian Federation, Canada, Poland, Greec... and more
-
Swiss GO Trial GroupHoffmann-La Roche; Novartis Pharmaceuticals; AGO Study Group; Anticancer Fund,... and other collaboratorsRecruitingFallopian Tube Neoplasms | Peritoneal Neoplasms | Ovarian Neoplasm Epithelial | High-grade Serous Ovarian Carcinoma (HGSOC) | Low-grade Serous Ovarian Carcinoma (LGSOC) | Ovarian Endometrioid CarcinomaAustria, Switzerland, Germany
-
AmgenCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerUnited States, France, Italy, Spain, United Kingdom, Belgium, Canada, Poland, Switzerland, Korea, Republic of, Russian Federation, Hong Kong, Portugal, South Africa, Israel, Romania, Bulgaria, Greece, Australia, Sweden, Japan, Latvia and more
-
Quantgene Inc.UnknownMelanoma | Breast Cancer | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Pancreatic Adenocarcinoma | Ovarian Cancer | Bladder Cancer | Non-small Cell Lung Cancer | Other Cancer | Adrenocortical CancerSwitzerland, United States
-
ETOP IBCSG Partners FoundationBristol-Myers Squibb; Frontier Science Foundation, HellasCompletedNon-small Cell Lung Cancer Stage IIISwitzerland, Netherlands, Spain, Belgium, Germany
-
University of ZurichWithdrawnAdenocarcinoma | Stomach Cancer | Cancer of Esophagogastric JunctionSwitzerland